Search

everythinglearnresearchcommunity

for

Search:↓

Chronic kidney disease can cause skin problems that affect patient quality of life, and treating these conditions can improve outcomes.

People with advanced chronic kidney disease often have skin problems, which can be treated with various medications and procedures to improve their quality of life.

Most patients with chronic kidney disease have skin problems, which get worse as the disease progresses, and dialysis doesn't greatly reduce these issues.

Almost all patients with chronic kidney disease not yet on dialysis have at least one skin problem.

Vitamin D and estrogen may help protect heart and kidney health, and maintaining sufficient vitamin D levels could be especially beneficial for African Americans, postmenopausal women, and people with chronic kidney disease.

Some growth factors, while important for normal body functions, can cause diseases when not regulated properly.

The meeting discussed medical findings, including benefits of certain treatments for cancer and heart conditions, and highlighted issues like poor adherence to preventive measures and skill gaps among interns.

Patients with chronic kidney disease often have various skin problems that affect their quality of life, but early treatment can help.

Patients on long-term hemodialysis often have skin problems related to their treatment.

Transplant patients often get skin problems, with treatments varying by condition.

Different types of fibroblasts play various roles in kidney repair and aging, and may affect chronic kidney disease outcomes.

Patients with chronic kidney disease on hemodialysis often have skin problems.

Chronic kidney disease can cause hair loss, which may be related to zinc deficiency or certain medications, and sometimes hair grows back when the underlying issue is treated.

Women and men experience different quality of life and symptom distress after kidney transplant with immunosuppressive therapy.

The conference presented findings on how vitamin D levels, genetic factors, and lifestyle choices like smoking and yoga affect various health conditions and diseases.

The Wnt/β-catenin pathway is important for tissue development and has potential in regenerative medicine, but requires more research for therapeutic use.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Long COVID patients have more health issues than non-infected people.

Skin doctors should know about skin and kidney disease links to prevent serious kidney problems.

Low dose oral minoxidil can help with hair growth but may cause serious heart problems, so doctors need to be careful.

Men with early balding should be checked for metabolic syndrome, as there's a link between the two.

Hair samples can reliably monitor tacrolimus levels in kidney transplant patients.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

Most patients with Systemic Lupus Erythematosus experience fatigue, skin issues, and joint pain.

Long COVID causes a wide range of long-lasting symptoms that change over time and are hard to diagnose and treat.

Metatrials could improve clinical research in nephrology by speeding up data collection and overcoming challenges like patient recruitment.

Progeroid mouse models show signs of early aging similar to humans, helping us understand aging better.

Mesenchymal stem cells could help treat aging-related diseases better than current methods.

Rare ULBP3 gene changes may raise the risk of Alopecia areata, a certain FAS gene deletion could cause a dysfunctional protein in an immune disorder, and having one copy of a specific genetic deletion is okay, but two copies cause sickle cell disease.